Research Papers

15 of 1340 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Disturbance of inorganic phosphate metabolism in diabetes mellitus: temporary therapeutic intervention trials.
Ditzel J; Lervang HH.
Diabetes Metab Syndr Obes (Unknown)
Published: 2009
1/6 Transparent
Self-monitoring of blood glucose in noninsulin-treated type 2 diabetes: an overview.
Kleefstra N; Hortensius J; van Hateren KJ; Logtenberg SJ; Houweling ST; Gans RO; Bilo HJ.
Diabetes Metab Syndr Obes (Unknown)
Published: 2009
1/6 Transparent
Insulin glulisine in the management of diabetes.
Yamada S.
Diabetes Metab Syndr Obes (Unknown)
Published: 2009
1/6 Transparent
p38 MAPK inhibition reduces diabetes-induced impairment of wound healing.
Medicherla S; Wadsworth S; Cullen B; Silcock D; Ma JY; Mangadu R; Kerr I; Chakravarty S; Luedtke GL; Dugar S; Protter AA; Higgins LS.
Diabetes Metab Syndr Obes (Unknown)
Published: 2009
1/6 Transparent
Inhibition of dipeptidyl peptidase-4: The mechanisms of action and clinical use of vildagliptin for the management of t…
Smushkin G; Vella A.
Diabetes Metab Syndr Obes (Unknown)
Published: 2009
2/6 Transparent
Funding Declared
Management of gestational diabetes mellitus.
Lapolla A; Dalfrà MG; Fedele D.
Diabetes Metab Syndr Obes (Unknown)
Published: 2009
1/6 Transparent
Biphasic insulin aspart 30/70 (BIAsp 30) in the treatment of type 1 and type 2 diabetes.
Valensi P.
Diabetes Metab Syndr Obes (Unknown)
Published: 2009
1/6 Transparent
Risk management in the treatment of type 2 diabetes with pioglitazone.
Derosa G; Salvadeo SA.
Diabetes Metab Syndr Obes (Unknown)
Published: 2009
1/6 Transparent
Sitagliptin as combination therapy in the treatment of type 2 diabetes mellitus.
Miller SA; St Onge EL; Accardi JR.
Diabetes Metab Syndr Obes (Unknown)
Published: 2009
1/6 Transparent
Improving glycemic and cholesterol control through an integrated approach incorporating colesevelam - a clinical perspe…
Goldberg RB.
Diabetes Metab Syndr Obes (Unknown)
Published: 2009
2/6 Transparent
Funding Declared
Assessing the impact of a new delivery method of insulin on glycemic control using a novel trial design.
Strack T; Martinez L; Del Prato S; Blonde L; Göke B; Woo V; Millward A; Gomis R; Canovatchel B; Lawrence D; Freemantle N.
Diabetes Metab Syndr Obes (Unknown)
Published: 2009
2/6 Transparent
Funding Declared
Role and development of GLP-1 receptor agonists in the management of diabetes.
Chia CW; Egan JM.
Diabetes Metab Syndr Obes (Unknown)
Published: 2009
2/6 Transparent
Funding Declared
Comorbidity and glycemia control among patients with type 2 diabetes in primary care.
Hudon C; Fortin M; Dubois MF; Almirall J.
Diabetes Metab Syndr Obes (Unknown)
Published: 2008
2/6 Transparent
Funding Declared
Assessing the effect of weight and weight loss in obese persons with type 2 diabetes.
Curtis B; Hayes RP; Fehnel S; Zografos L.
Diabetes Metab Syndr Obes (Unknown)
Published: 2008
2/6 Transparent
Funding Declared
Insulin autoimmune syndrome in a patient with ANCA-associated glomerulonephritis.
Ka T; Moriwaki Y; Nakanishi T; Yamamoto T.
Diabetes Metab Syndr Obes (Unknown)
Published: 2008
1/6 Transparent